Category: GEGI

A Way Forward for Equitable Pharmaceutical Access After COVID-19

By Brook Baker and Rachel Thrasher COVID-19 exploded on a global stage dominated by an international legal and policy regime that instantiates closed science, intellectual property (IP) monopolies and privatized control over the testing, supply, price and distribution of life-saving health technologies. As a result, there were avoidable delays in biopharmaceutical preparedness, ill-adapted technologies that […]

From Business as Usual to Health for the Future: Challenging the Intellectual Property Regime to Address COVID-19 and Future Pandemics

COVID-19 has been met by an international legal and policy regime of closed science, intellectual property monopolies and privatized control over the testing, supply, price and distribution of life-saving health technologies. Despite the remarkable effectiveness of the currently available vaccines, almost one-third of the world remains unvaccinated, allowing the pandemic to continue in many low- […]

Understanding AMRO’s Nested Outgrowth from the IMF

By Yaechan Lee The International Monetary Fund (IMF) continues to be the focal institution in the Global Financial Safety Net (GFSN), which refers to a set of institutions and mechanisms that provide insurance against crises and financing to mitigate their impact. Yet, the IMF’s stringent conditionalities that were often perceived to ignore country-specificities, and the […]

Nested Outgrowth: Complementing Regional Surveillance Under Limited Capacity

The rise of regional financial arrangements (RFAs) over the last two decades has significantly reshaped the Global Financial Security Net (GFSN), which was previously almost the sole purview of the International Monetary Fund (IMF). While the rise in regionally based financial resources has been widely noted, as have the challenges of coordinating IMF and RFA […]

The International Monetary Fund and Quota Reform: Background and Key Considerations

As the global economy faces increasing challenges in the aftermath of the COVID-19 pandemic, and as interest rates continue to rapidly rise in the United States and across the Global North, emerging market and developing economies (EMDEs) are facing a perfect storm of high inflation, increased borrowing costs and surging debt levels. Against this backdrop, […]

Webinar Summary – The 2023 Paul Streeten Distinguished Lecture in Global Development Policy: The Blurred Contours of a New International Economic Order

By Timon Forster On March 29, 2023, the Boston University Global Development Policy Center, the Institute for Economic Development and the Department of Economics hosted its annual Paul Streeten Distinguished Lecture in Global Development Policy, which celebrates the legacy of BU Professor Paul Streeten as an eminent economist and interdisciplinary scholar of global development policy. […]

How the IMF Can Foster Inclusive Growth and Development in a Global Climate Transition

By Marilou Uy and Rishikesh Ram Bhandary The global transformation to achieve low-carbon and climate-resilient development poses macro-critical challenges for countries around the world. Countries need to accelerate the shift to low-carbon investments, build resilience to climate shocks, contend with loss and damage and navigate the cross-border impacts of the climate transition. Developing countries alone […]

Scaling Up Climate Adaptation Finance in Times of Growing Public Debt, Inflation and Natural Disasters

In 2021, economic losses from natural catastrophes totaled $270 billion. Poor climate physical risk assessment limits adaptation finance, which is still lagging behind mitigation finance in emerging markets and developing economies (EMDEs), but also high-income countries. A new policy brief  published by the European Capital Markets Institute and authored by Irene Monasterolo, Kevin P. Gallagher, […]